Conference Details - Agenda
View all Conferences
This activity is approved for AMA PRA Category 1 Credit™
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.
Continuing Education Information
Physicians: Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.This activity is approved for AMA PRA Category 1 Credit™
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.
Seventh International Congress on Targeted Therapies in Cancer
Renaissance Mayflower Hotel
Washington, DC
August 22-24, 2008
Friday, Aug 22, 2008
| 7:30 am | Registration and Continental Breakfast |
| 8:00 am | Welcome and Introductions |
| 8:05 am | Presession Survey |
| Keynote Lecture | |
| 8:15 am | Unraveling Signal Transduction: Separating Real Targets From Noise Gordon Mills |
| 8:55 am | Question-and-Answer Session |
| Targeting Cell Surface Receptors and Ligands | |
| 9:00 am | Overview of Growth Factor Receptor Signaling Douglas Yee |
| 9:25 am | Question-and-Answer Session |
| 9:30 am | Improving Unconjugated MoAb Therapy Louis M. Weiner |
| 9:55 am | Question-and-Answer Session |
| 10:00 am | Angiopoietin and Other Novel Targets Michael S. Gordon |
| 10:25 am | Question-and-Answer Session |
| 10:30 am | Agents Targeting the IGF/IGFR Axis Anthony Tolcher |
| 10:55 am | Question-and-Answer Session |
| 11:00 am | Break |
| 11:15 am | Agents Targeting the c-Met Receptor Patricia LoRusso |
| 11:40 am | Question-and-Answer Session |
| 11:45 am | Panel Discussion |
| Targeting Intracellular Signaling | |
| 12:05 am | HSP90 Inhibitors Shanu Modi |
| 12:30 pm | Question-and-Answer Session |
| 12:35 pm | Lunch |
| 1:20 pm | Inhibitors of PI3K Ramesh K. Ramanathan |
| 1:45 pm | Question-and-Answer Session |
| 1:50 pm | Akt and Src Inhibitors Howard A. Burris III |
| 2:15 pm | Question-and-Answer Session |
| 2:20 pm | Postsession Survey |
| 2:25 pm | Panel Discussion |
| Boosting the Immune System | |
| 2:45 pm | Presession Survey |
| 2:55 pm | Lung Cancer Vaccines (Including BLP25 and MAGE A3) Nevin Murray |
| 3:10 pm | Question-and-Answer Session |
| 3:15 pm | Breast Cancer Vaccines Mary L. (Nora) Disis |
| 3:30 pm | Question-and-Answer Session |
| 3:35 pm | Panel Discussion |
| 3:55 pm | Break |
| Therapeutic Discovery Platforms | |
| 4:10 pm | Adnectins: A Novel Class of Protein Therapeutics Eric Furfine |
| 4:25 pm | Question-and-Answer Session |
| 4:30 pm | Antisense Molecules Ivan Horak |
| 4:45 pm | Question-and-Answer Session |
| 4:50 pm | RNAi Strategies Mark Davis |
| 5:05 pm | Question-and-Answer Session |
| 5:10 pm | Multitargeted Small Molecules Against HDACs/RTKs William Munger |
| 5:25 pm | Question-and-Answer Session |
| 5:30 pm | Postsession Survey |
| 5:45 pm | Panel Discussion |
| 5:55 pm | Adjourn |
Educational Grants
An educational grant for this activity was provided by:
- Genentech BioOncology
- Amgen
- Merck Oncology
- sanofi-aventis U.S.
- AstraZeneca
- Bristol-Myers Squibb/
ImClone Systems - OSI Oncology
- Wyeth Pharmaceuticals
- ImClone Systems